BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5082973)

  • 21. [Copper metabolism disorders as an attempt at explaining analogous pathological mechanisms in Wilson's syndrome and severe cases of liver cirrhosis].
    Pawlak J
    Wiad Lek; 1975 Jun; 28(12):1041-4. PubMed ID: 1136474
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physiopathology of hepatolenticular degeneration (Wilson's disease)].
    Willvonseder R
    Wien Z Inn Med; 1973; 54(11-12):544-58. PubMed ID: 4804125
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1967 Feb; 1(7486):346-50. PubMed ID: 4163882
    [No Abstract]   [Full Text] [Related]  

  • 24. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
    Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
    J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of genetic and acquired liver defects on radio-copper turnover in Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1969 Jul; 2(7610):17-20. PubMed ID: 4182791
    [No Abstract]   [Full Text] [Related]  

  • 27. Copper metabolism in Wilson's disease.
    WINTROBE MM; CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; BEAN WB
    Trans Assoc Am Physicians; 1954; 67():232-41. PubMed ID: 13216832
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper kinetics in liver disease.
    Smallwood RA; McIlveen B; Rosenoer VM; Sherlock S
    Gut; 1971 Feb; 12(2):139-44. PubMed ID: 5548560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 31. [Copper metabolism after living related liver transplantation for Wilson's disease].
    Wang XH; Cheng F; Zhang F; Li XC; Li GQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):303. PubMed ID: 15161511
    [No Abstract]   [Full Text] [Related]  

  • 32. Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease?
    Diaz J; Acosta F; Cañizares F; Bueno FS; Tornel PL; Tovar I; Contreras RF; Marquez M; Martinez P; Parrilla P
    Transplant Proc; 1995 Aug; 27(4):2306. PubMed ID: 7652819
    [No Abstract]   [Full Text] [Related]  

  • 33. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
    Sato M; Hayashi A; Ito H; Tojo M; Arima M
    No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease).
    UZMAN LL; IBER FL; CHALMERS TC
    Am J Med Sci; 1956 May; 231(5):511-8. PubMed ID: 13313537
    [No Abstract]   [Full Text] [Related]  

  • 35. Monitoring copper in Wilson's disease.
    Walshe JM
    Adv Clin Chem; 2010; 50():151-63. PubMed ID: 20521445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of the physiology of copper in Wilson's disease. II. The internal kinetics of copper.
    O'Reilly S; Pollycove M; Tono M; Herradora L
    Arch Neurol; 1971 Jun; 24(6):481-8. PubMed ID: 5089893
    [No Abstract]   [Full Text] [Related]  

  • 37. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic pathways of red blood cell copper in normal humans and in Wilson's disease.
    Neumann PZ; Silverberg M
    Nature; 1967 Feb; 213(5078):775-9. PubMed ID: 6031801
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of Wilson's disease with an atypical clinical course].
    Michałowska-Kurowska M; Czajka M; Kadylak B
    Pol Merkur Lekarski; 1996 Sep; 1(3):204-6. PubMed ID: 9139791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper distribution in Wilson's disease.
    Stömmer PE
    Arch Pathol Lab Med; 1983 Oct; 107(10):554. PubMed ID: 6688520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.